Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-029004
Filing Date
2020-05-13
Accepted
2020-05-13 19:32:39
Documents
1
Period of Report
2020-05-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3994
  Complete submission text file 0001209191-20-029004.txt   5496
Mailing Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Issuer) CIK: 0001653087 (see all company filings)

EIN.: 462702363 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ALECTOR, INC. 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address
Yaffe Kristine (Reporting) CIK: 0001783895 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38792 | Film No.: 20874916